NewcelX Ltd. (NCEL) reporting calendar
NewcelX Ltd. files periodic reports with the SEC as NCEL on Nasdaq. Atlas tracks 6 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 29 Apr 2026
- Reports on record
- 6
Open NCEL market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 29 Apr 2026 | 119 days | 0001213900-26-049307 |
| 20-F | 31 Dec 2024 | 16 May 2025 | 136 days | 0001213900-25-044868 |
| 20-F | 31 Dec 2023 | 15 May 2024 | 136 days | 0001213900-24-043570 |
| 20-F | 31 Dec 2022 | 5 May 2023 | 125 days | 0001213900-23-036920 |
| 20-F | 31 Dec 2021 | 24 Mar 2022 | 83 days | 0001213900-22-014905 |
| 20-F | 31 Dec 2020 | 14 May 2021 | 134 days | 0001213900-21-026511 |
Source: SEC EDGAR company submissions for CIK 0001783036. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.